Procter & Gamble Hygiene and Health Care Ltd
Procter & Gamble Hygiene and Health Care Ltd (PGHH) is scheduled to report results on 12 Nov 2026. Procter & Gamble Hygiene and Health Care Ltd last reported results for the quarter ended Jun 2026, with sales of ₹891 crore and net profit of ₹126 crore. The stock last traded at ₹6,942, a market capitalisation of ₹22,563 crore, on a P/E of 28.5. Over the past 52 weeks the stock has ranged between ₹6,576 and ₹14,352. Figures are as of 9 Oct 2026 and are not real time.
Procter & Gamble Hygiene and Health Care Ltd share price and key metrics
- Current price
- ₹6,942
- Market cap
- ₹22,563 cr
- Stock P/E
- 28.5
- Book value
- ₹232
- ROE
- 115%
- ROCE
- 157%
- Dividend yield
- 3.31%
- 52w high / low
- 14352/6576
Metrics as of 9 Oct 2026. Not real time.
Track Procter & Gamble Hygiene and Health Care Ltd
Cruxal reads every Procter & Gamble Hygiene and Health Care Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Procter & Gamble Hygiene and Health Care Ltd growth and returns
- 10 Years
- 6%
- 5 Years
- 7%
- 3 Years
- 3%
- TTM
- -2%
- 10 Years
- 9%
- 5 Years
- 14%
- 3 Years
- 14%
- TTM
- -5%
- 10 Years
- 0%
- 5 Years
- -13%
- 3 Years
- -27%
- 1 Year
- -51%
- 10 Years
- 60%
- 5 Years
- 83%
- 3 Years
- 89%
- Last Year
- 115%
Procter & Gamble Hygiene and Health Care Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹891 cr, down 4.9% from ₹937 cr a year earlier. Net profit was ₹126 cr, down 34.4% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 1,135 | 1,248 | 992 | 937 | 1,150 | 1,262 | 941 | 891 |
| Expenses | 845 | 877 | 782 | 671 | 865 | 860 | 723 | 721 |
| Operating profit | 290 | 371 | 210 | 266 | 285 | 402 | 218 | 170 |
| OPM % | 26% | 30% | 21% | 28% | 25% | 32% | 23% | 19% |
| Other income | 8 | 10 | 19 | 8 | 10 | 12 | 12 | 9 |
| Interest | 2 | 7 | 6 | 0 | 4 | 3 | 3 | 0 |
| Depreciation | 12 | 10 | 10 | 9 | 9 | 10 | 10 | 10 |
| Profit before tax | 285 | 364 | 213 | 265 | 282 | 402 | 218 | 170 |
| Tax % | 26% | 26% | 27% | 27% | 26% | 25% | 30% | 26% |
| Net profit | 212 | 269 | 156 | 192 | 210 | 301 | 153 | 126 |
| EPS (₹) | 65.28 | 82.74 | 48.09 | 59.17 | 64.65 | 92.87 | 47.17 | 38.90 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Procter & Gamble Hygiene and Health Care Ltd annual results
| ₹ crore | Jun 2017 | Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2,320 | 2,455 | 2,947 | 3,002 | 3,574 | 3,901 | 3,918 | 4,206 | 3,374 | 4,290 | 4,245 |
| Operating profit | 675 | 622 | 618 | 606 | 886 | 832 | 869 | 976 | 871 | 1,171 | 1,075 |
| OPM % | 29% | 25% | 21% | 20% | 25% | 21% | 22% | 23% | 26% | 27% | 25% |
| Net profit | 433 | 375 | 419 | 433 | 652 | 576 | 678 | 675 | 637 | 856 | 791 |
| EPS (₹) | 133.31 | 115.40 | 129.12 | 133.42 | 200.79 | 177.37 | 208.91 | 207.95 | 196.11 | 263.86 | 243.59 |
TTM is the trailing twelve months to the most recent quarter.
Procter & Gamble Hygiene and Health Care Ltd balance sheet
| ₹ crore | Jun 2017 | Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity capital | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 |
| Reserves | 494 | 773 | 877 | 1,125 | 682 | 705 | 914 | 742 | 705 | 721 |
| Borrowings | 0 | 0 | 0 | 0 | 3 | 5 | 4 | 3 | 2 | 1 |
| Other liabilities | 634 | 620 | 708 | 671 | 915 | 940 | 1,187 | 1,081 | 1,015 | 1,049 |
| Total liabilities | 1,160 | 1,425 | 1,617 | 1,828 | 1,633 | 1,683 | 2,137 | 1,859 | 1,755 | 1,804 |
| Fixed assets | 286 | 250 | 234 | 206 | 184 | 164 | 170 | 139 | 131 | 163 |
| CWIP | 41 | 21 | 15 | 22 | 38 | 44 | 23 | 28 | 41 | 21 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other assets | 834 | 1,154 | 1,368 | 1,600 | 1,411 | 1,475 | 1,945 | 1,692 | 1,583 | 1,619 |
| Total assets | 1,160 | 1,425 | 1,617 | 1,828 | 1,633 | 1,683 | 2,137 | 1,859 | 1,755 | 1,804 |
As reported by the company. Total assets equal total liabilities by construction.
Procter & Gamble Hygiene and Health Care Ltd cash flow
| ₹ crore | Jun 2017 | Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 445 | 415 | 413 | 474 | 863 | 573 | 826 | 470 | 598 | 924 |
| Cash from investing | 149 | -19 | 34 | 75 | 7 | -27 | -10 | 1 | -34 | 11 |
| Cash from financing | -1,559 | -106 | -314 | -190 | -1,106 | -569 | -477 | -861 | -671 | -845 |
| Net cash flow | -964 | 290 | 134 | 358 | -236 | -23 | 339 | -390 | -107 | 91 |
| Free cash flow | 401 | 377 | 410 | 423 | 832 | 523 | 781 | 427 | 544 | 893 |
| CFO / operating profit | 103% | 111% | 105% | 102% | 126% | 99% | 121% | 79% | 96% | 105% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
Procter & Gamble Hygiene and Health Care Ltd operating ratios
| Per year | Jun 2017 | Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % | 64% | 89% | 73% | 58% | 94% | 110% | 101% | 112% | 104% | 157% |
| Debtor days | 21 | 22 | 22 | 20 | 15 | 18 | 20 | 21 | 33 | 21 |
| Inventory days | 71 | 48 | 60 | 68 | 78 | 55 | 48 | 51 | 64 | 51 |
| Days payable | 145 | 156 | 162 | 175 | 237 | 183 | 213 | 193 | 235 | 197 |
| Cash conversion cycle | -53 | -87 | -79 | -87 | -144 | -110 | -145 | -121 | -138 | -126 |
| Working capital days | -15 | -23 | -12 | -21 | -39 | -34 | -53 | -32 | -30 | -31 |
Ratios as computed by the source from the reported statements. Rows a company does not report are omitted.
Procter & Gamble Hygiene and Health Care Ltd shareholding pattern
Promoters held 70.64% at Jun 2026, broadly unchanged since Jun 2025. FIIs 0.98% and DIIs 15.58%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 70.64% | 70.64% | 70.64% | 70.64% | 70.64% | 70.64% | 70.64% | 70.64% |
| FIIs | 1.48% | 1.43% | 1.33% | 1.38% | 1.11% | 1.06% | 0.97% | 0.98% |
| DIIs | 15.28% | 15.37% | 15.50% | 15.49% | 16.05% | 16.03% | 15.96% | 15.58% |
| Public | 12.60% | 12.56% | 12.52% | 12.48% | 12.19% | 12.25% | 12.43% | 12.79% |
| No. of shareholders | 42,348 | 42,941 | 44,877 | 47,891 | 49,997 | 50,969 | 53,416 | 57,957 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
When is Procter & Gamble Hygiene and Health Care Ltd’s next results date?
Procter & Gamble Hygiene and Health Care Ltd’s next results are scheduled for 12 Nov 2026.
- Earnings resultsConsider and approve the Unaudited Financial Results for the quarter and half year ended September 30, 2026
See the full results calendar for every Indian company reporting in the next 30 days.
Procter & Gamble Hygiene and Health Care Ltd corporate filings
- The Company has submitted Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended September 30, 2026Company Updatelow impact
- Procter & Gamble Hygiene and Health Care Limited schedules Board Meeting for November 12, 2026, to approve Q2 FY27 financial resultsBoard Meetinglow impact
Cruxal's analysis: Procter & Gamble Hygiene and Health Care Limited has formally intimated the stock…
Read the full analysis - The Company has informed the Exchange regarding closure of trading window for the quarter ended September 30, 2026Insider Trading / SASTlow impact
- Procter & Gamble Hygiene and Health Care Limited announces appointment of new Company Secretary and Compliance OfficerCompany Updatelow impact
Cruxal's analysis: Procter & Gamble Hygiene and Health Care Limited has appointed Ms. Flavia Machado as the…
Read the full analysis - Procter & Gamble Hygiene and Health Care Ltd clarifies on material price movementOtherslow impact
Cruxal's analysis: The company has submitted a clarification to the stock exchange regarding recent material…
Read the full analysis - Procter & Gamble Hygiene and Health Care Ltd issues update on special window for physical securities dematerializationCompany Updatelow impact
Cruxal's analysis: The company has provided a routine regulatory intimation regarding the special window for…
Read the full analysis - Procter & Gamble Hygiene and Health Care Limited confirms shareholder approval for appointment of Ms. Srividya Srinivasan as Whole-time DirectorCompany Updatelow impact
Cruxal's analysis: Procter & Gamble Hygiene and Health Care Limited has formally announced that shareholders…
Read the full analysis - Procter & Gamble Hygiene and Health Care Limited concludes 62nd AGM with approval of all resolutionsAGM/EGMlow impact
Cruxal's analysis: Procter & Gamble Hygiene and Health Care Limited has successfully concluded its 62nd…
Read the full analysis - Procter & Gamble Hygiene and Health Care Limited Reports Flat Sales and 19% PAT Growth for Fiscal Year 2025-26AGM/EGMlow impact
Cruxal's analysis: Procter & Gamble Hygiene and Health Care Limited (PGHH) held its 62nd Annual General…
Read the full analysis - Procter & Gamble Hygiene and Health Care Ltd releases Annual Report for FY 2025-26Otherslow impact
Cruxal's analysis: Procter & Gamble Hygiene and Health Care Ltd has filed its Annual Report for the…
Read the full analysis - Procter & Gamble Hygiene and Health Care Ltd files Business Responsibility and Sustainability Report (BRSR) for FY 2025-26Otherslow impact
Cruxal's analysis: Procter & Gamble Hygiene and Health Care Ltd has submitted its Business Responsibility…
Read the full analysis - Procter & Gamble Hygiene and Health Care Limited Announces 62nd AGM and Material Related Party TransactionAGM/EGMhigh impact
Cruxal's analysis: Procter & Gamble Hygiene and Health Care Limited has issued a notice for its 62nd Annual…
Read the full analysis - Procter & Gamble Hygiene and Health Care Limited announces updated schedule for 62nd AGM and dividend record dateAGM/EGMlow impact
Cruxal's analysis: Procter & Gamble Hygiene and Health Care Limited has formally notified the exchanges of…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.